Epidural Catheter
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Hepatitis B Vaccines Market Outlook 2023
1 Hepatitis B Vaccines Market Overview
1.1 Product Overview and Scope of Hepatitis B Vaccines
1.2 Hepatitis B Vaccines Segment by Type
1.2.1 Global Hepatitis B Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Hepatitis B Vaccines Segment by Application
1.3.1 Global Hepatitis B Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Children
1.3.3 Adult
1.4 Global Hepatitis B Vaccines Market Size Estimates and Forecasts
1.4.1 Global Hepatitis B Vaccines Revenue 2016-2027
1.4.2 Global Hepatitis B Vaccines Sales 2016-2027
1.4.3 Hepatitis B Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027
2 Hepatitis B Vaccines Market Competition by Manufacturers
2.1 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Hepatitis B Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Hepatitis B Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Hepatitis B Vaccines Market Competitive Situation and Trends
2.5.1 Hepatitis B Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Hepatitis B Vaccines Players Market Share by Revenue
2.5.3 Global Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatitis B Vaccines Retrospective Market Scenario by Region
3.1 Global Hepatitis B Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Hepatitis B Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Hepatitis B Vaccines Market Facts & Figures by Country
3.3.1 North America Hepatitis B Vaccines Sales by Country
3.3.2 North America Hepatitis B Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Hepatitis B Vaccines Market Facts & Figures by Country
3.4.1 Europe Hepatitis B Vaccines Sales by Country
3.4.2 Europe Hepatitis B Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hepatitis B Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Hepatitis B Vaccines Sales by Region
3.5.2 Asia Pacific Hepatitis B Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Hepatitis B Vaccines Market Facts & Figures by Country
3.6.1 Latin America Hepatitis B Vaccines Sales by Country
3.6.2 Latin America Hepatitis B Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Hepatitis B Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Hepatitis B Vaccines Sales by Country
3.7.2 Middle East and Africa Hepatitis B Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Hepatitis B Vaccines Historic Market Analysis by Type
4.1 Global Hepatitis B Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Hepatitis B Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Hepatitis B Vaccines Price by Type (2016-2021)
5 Global Hepatitis B Vaccines Historic Market Analysis by Application
5.1 Global Hepatitis B Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Hepatitis B Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Hepatitis B Vaccines Price by Application (2016-2021)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GSK Hepatitis B Vaccines Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 NCPC
6.2.1 NCPC Corporation Information
6.2.2 NCPC Description and Business Overview
6.2.3 NCPC Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 NCPC Hepatitis B Vaccines Product Portfolio
6.2.5 NCPC Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck Hepatitis B Vaccines Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Bio Kangtai
6.4.1 Bio Kangtai Corporation Information
6.4.2 Bio Kangtai Description and Business Overview
6.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bio Kangtai Hepatitis B Vaccines Product Portfolio
6.4.5 Bio Kangtai Recent Developments/Updates
6.5 Dynavax
6.5.1 Dynavax Corporation Information
6.5.2 Dynavax Description and Business Overview
6.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Dynavax Hepatitis B Vaccines Product Portfolio
6.5.5 Dynavax Recent Developments/Updates
6.6 Hissen
6.6.1 Hissen Corporation Information
6.6.2 Hissen Description and Business Overview
6.6.3 Hissen Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Hissen Hepatitis B Vaccines Product Portfolio
6.6.5 Hissen Recent Developments/Updates
6.7 KM Biologics
6.6.1 KM Biologics Corporation Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 KM Biologics Hepatitis B Vaccines Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 LG Life Sciences
6.8.1 LG Life Sciences Corporation Information
6.8.2 LG Life Sciences Description and Business Overview
6.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 LG Life Sciences Hepatitis B Vaccines Product Portfolio
6.8.5 LG Life Sciences Recent Developments/Updates
6.9 Serum Institute
6.9.1 Serum Institute Corporation Information
6.9.2 Serum Institute Description and Business Overview
6.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Serum Institute Hepatitis B Vaccines Product Portfolio
6.9.5 Serum Institute Recent Developments/Updates
7 Hepatitis B Vaccines Manufacturing Cost Analysis
7.1 Hepatitis B Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hepatitis B Vaccines
7.4 Hepatitis B Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hepatitis B Vaccines Distributors List
8.3 Hepatitis B Vaccines Customers
9 Hepatitis B Vaccines Market Dynamics
9.1 Hepatitis B Vaccines Industry Trends
9.2 Hepatitis B Vaccines Growth Drivers
9.3 Hepatitis B Vaccines Market Challenges
9.4 Hepatitis B Vaccines Market Restraints
10 Global Market Forecast
10.1 Hepatitis B Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hepatitis B Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Hepatitis B Vaccines by Type (2022-2027)
10.2 Hepatitis B Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hepatitis B Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Hepatitis B Vaccines by Application (2022-2027)
10.3 Hepatitis B Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hepatitis B Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Hepatitis B Vaccines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Hepatitis B Vaccines Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Hepatitis B Vaccines Sales (M Doses) Comparison by Application (2021-2027)
Table 3. Global Hepatitis B Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Hepatitis B Vaccines Covered in This Study
Table 5. Global Hepatitis B Vaccines Sales (M Doses) of Key Manufacturers (2016-2021)
Table 6. Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Hepatitis B Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Hepatitis B Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Hepatitis B Vaccines Average Price (USD/Doses) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Hepatitis B Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Hepatitis B Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis B Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Hepatitis B Vaccines Sales by Region (2016-2021) & (M Doses)
Table 16. Global Hepatitis B Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Hepatitis B Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Hepatitis B Vaccines Sales by Country (2016-2021) & (M Doses)
Table 19. North America Hepatitis B Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Hepatitis B Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Hepatitis B Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Hepatitis B Vaccines Sales by Country (2016-2021) & (M Doses)
Table 23. Europe Hepatitis B Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Hepatitis B Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Hepatitis B Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Hepatitis B Vaccines Sales by Region (2016-2021) & (M Doses)
Table 27. Asia Pacific Hepatitis B Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Hepatitis B Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Hepatitis B Vaccines Sales by Country (2016-2021) & (M Doses)
Table 31. Latin America Hepatitis B Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Hepatitis B Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Hepatitis B Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Hepatitis B Vaccines Sales by Country (2016-2021) & (M Doses)
Table 35. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Hepatitis B Vaccines Sales (M Doses) by Type (2016-2021)
Table 39. Global Hepatitis B Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Hepatitis B Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Hepatitis B Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2016-2021)
Table 43. Global Hepatitis B Vaccines Sales (M Doses) by Application (2016-2021)
Table 44. Global Hepatitis B Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Hepatitis B Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Hepatitis B Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2016-2021)
Table 48. GSK Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 51. GSK Hepatitis B Vaccines Product
Table 52. GSK Recent Developments/Updates
Table 53. NCPC Corporation Information
Table 54. NCPC Description and Business Overview
Table 55. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 56. NCPC Hepatitis B Vaccines Product
Table 57. NCPC Recent Developments/Updates
Table 58. Merck Corporation Information
Table 59. Merck Description and Business Overview
Table 60. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 61. Merck Hepatitis B Vaccines Product
Table 62. Merck Recent Developments/Updates
Table 63. Bio Kangtai Corporation Information
Table 64. Bio Kangtai Description and Business Overview
Table 65. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 66. Bio Kangtai Hepatitis B Vaccines Product
Table 67. Bio Kangtai Recent Developments/Updates
Table 68. Dynavax Corporation Information
Table 69. Dynavax Description and Business Overview
Table 70. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 71. Dynavax Hepatitis B Vaccines Product
Table 72. Dynavax Recent Developments/Updates
Table 73. Hissen Corporation Information
Table 74. Hissen Description and Business Overview
Table 75. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 76. Hissen Hepatitis B Vaccines Product
Table 77. Hissen Recent Developments/Updates
Table 78. KM Biologics Corporation Information
Table 79. KM Biologics Description and Business Overview
Table 80. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 81. KM Biologics Hepatitis B Vaccines Product
Table 82. KM Biologics Recent Developments/Updates
Table 83. LG Life Sciences Corporation Information
Table 84. LG Life Sciences Description and Business Overview
Table 85. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 86. LG Life Sciences Hepatitis B Vaccines Product
Table 87. LG Life Sciences Recent Developments/Updates
Table 88. Serum Institute Corporation Information
Table 89. Serum Institute Description and Business Overview
Table 90. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/Doses) and Gross Margin (2016-2021)
Table 91. Serum Institute Hepatitis B Vaccines Product
Table 92. Serum Institute Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Hepatitis B Vaccines Distributors List
Table 96. Hepatitis B Vaccines Customers List
Table 97. Hepatitis B Vaccines Market Trends
Table 98. Hepatitis B Vaccines Growth Drivers
Table 99. Hepatitis B Vaccines Market Challenges
Table 100. Hepatitis B Vaccines Market Restraints
Table 101. Global Hepatitis B Vaccines Sales Forecast by Type (2022-2027) & (M Doses)
Table 102. Global Hepatitis B Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 103. Global Hepatitis B Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 104. Global Hepatitis B Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 105. Global Hepatitis B Vaccines Sales Forecast by Application (2022-2027) & (M Doses)
Table 106. Global Hepatitis B Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 107. Global Hepatitis B Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 108. Global Hepatitis B Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 109. Global Hepatitis B Vaccines Sales Forecast by Region (2022-2027) & (M Doses)
Table 110. Global Hepatitis B Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 111. Global Hepatitis B Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 112. Global Hepatitis B Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatitis B Vaccines
Figure 2. Global Hepatitis B Vaccines Market Share by Type in 2020 & 2027
Figure 3. Yeast Derived Product Picture
Figure 4. CHO Derived Product Picture
Figure 5. Global Hepatitis B Vaccines Market Share by Application in 2020 & 2027
Figure 6. Children
Figure 7. Adult
Figure 8. Global Hepatitis B Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Hepatitis B Vaccines Market Size 2016-2027 (US$ Million)
Figure 10. Global Hepatitis B Vaccines Sales 2016-2027 (M Doses)
Figure 11. Global Hepatitis B Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Hepatitis B Vaccines Sales Share by Manufacturers in 2020
Figure 13. Global Hepatitis B Vaccines Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Hepatitis B Vaccines Players: Market Share by Revenue in 2020
Figure 15. Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Hepatitis B Vaccines Sales Market Share by Region (2016-2021)
Figure 17. Global Hepatitis B Vaccines Sales Market Share by Region in 2020
Figure 18. Global Hepatitis B Vaccines Revenue Market Share by Region (2016-2021)
Figure 19. Global Hepatitis B Vaccines Revenue Market Share by Region in 2020
Figure 20. U.S. Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Hepatitis B Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Hepatitis B Vaccines by Type (2016-2021)
Figure 45. Sales Market Share of Hepatitis B Vaccines by Application (2016-2021)
Figure 46. Sales Market Share of Hepatitis B Vaccines by Application in 2020
Figure 47. Revenue Share of Hepatitis B Vaccines by Application (2016-2021)
Figure 48. Revenue Share of Hepatitis B Vaccines by Application in 2020
Figure 49. Manufacturing Cost Structure of Hepatitis B Vaccines
Figure 50. Manufacturing Process Analysis of Hepatitis B Vaccines
Figure 51. Hepatitis B Vaccines Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GSK NCPC Merck Bio Kangtai Dynavax Hissen KM Biologics LG Life Sciences Serum Institute